Furthermore, with no obvious side effects, ALT could synergistically enhance the cytotoxic effects with other anti-cancer agents, such as oxaliplatin (Cao et al., 2019) and olaparib (Wang et al., 2020) in vivo and in vitro. This evidence concerns the gene GPT and cancer.